493 related articles for article (PubMed ID: 12170401)
1. Differences in the diagnostic yield of upper gastrointestinal endoscopy in dyspeptic patients receiving proton-pump inhibitors and H2-receptor antagonists.
Mitchell RM; Collins JS; Watson RG; Tham TC
Endoscopy; 2002 Jul; 34(7):524-6. PubMed ID: 12170401
[TBL] [Abstract][Full Text] [Related]
2. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
3. Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors.
Smith T; Verzola E; Mertz H
Gastrointest Endosc; 2003 Jul; 58(1):9-13. PubMed ID: 12838213
[TBL] [Abstract][Full Text] [Related]
4. [Acid-related disease in the population of two Norwegian municipalities--diagnosis and drug therapy].
Vetvik K; Straand J
Tidsskr Nor Laegeforen; 2001 Feb; 121(5):557-62. PubMed ID: 11301609
[TBL] [Abstract][Full Text] [Related]
5. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
[TBL] [Abstract][Full Text] [Related]
6. [Survey of patients with upper gastrointestinal tract dyspepsia. A trial of H2 blocker therapy or endoscopy--a randomized trial of 2 management methods].
Bytzer P; Hansen JM; Schaffalitzky de Muckadell OB
Ugeskr Laeger; 1995 Feb; 157(7):893-7. PubMed ID: 7701651
[TBL] [Abstract][Full Text] [Related]
7. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
Laine L
Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
[TBL] [Abstract][Full Text] [Related]
8. [Is endoscopy necessary to initiate medical treatment in primary-level medical care patients with not investigated dyspepsia?].
López LH; Dibildox M; Ramírez Barba E; Vargas JA; Rábago M; González J; Montalvo-Jave E
Rev Gastroenterol Mex; 2003; 68(2):100-6. PubMed ID: 15127645
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for the management of dyspepsia.
Talley NJ; Vakil N;
Am J Gastroenterol; 2005 Oct; 100(10):2324-37. PubMed ID: 16181387
[TBL] [Abstract][Full Text] [Related]
10. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
[TBL] [Abstract][Full Text] [Related]
11. [Upper digestive tract hemorrhage; an assessment in the Amsterdam region].
Vreeburg EM; de Bruijne JW; Bartelsman JW; Wesdorp IC; Snel P
Ned Tijdschr Geneeskd; 1994 Oct; 138(41):2044-9. PubMed ID: 7935967
[TBL] [Abstract][Full Text] [Related]
12. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
13. [Use of the upper gastrointestinal endoscopy in dyspeptic patients].
Meirelles GS; Ornellas LC; de Mattos NL; Ornellas AT; de Souza AF
Arq Gastroenterol; 1998; 35(3):181-5. PubMed ID: 10029863
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
15. Audit of reflux oesophagitis at 4 years.
Pace F; Bollani S; Manzionna G; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):355-60. PubMed ID: 9789126
[TBL] [Abstract][Full Text] [Related]
16. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
Keyvani L; Murthy S; Leeson S; Targownik LE
Aliment Pharmacol Ther; 2006 Oct; 24(8):1247-55. PubMed ID: 17014584
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of symptom presentation in dyspeptic patients referred for upper gastrointestinal endoscopy in Estonia.
Kolk H
Croat Med J; 2004 Oct; 45(5):592-8. PubMed ID: 15495287
[TBL] [Abstract][Full Text] [Related]
18. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
[TBL] [Abstract][Full Text] [Related]
19. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
Chan J; Hui RL; Szpakowski JL
Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
[TBL] [Abstract][Full Text] [Related]
20. Open access endoscopy: a large-scale analysis of its use in dyspeptic patients.
Mansi C; Mela GS; Savarino V; Mele MR; Valle F; Celle G
J Clin Gastroenterol; 1993 Mar; 16(2):149-53; discussion 153-4. PubMed ID: 8463620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
